

Sep 7, 2026
Introducing Innovative Probiotics for Sleep Quality and Body Fat Management, Alongside Advanced Ingredient Technologies
ILDONG Bioscience explores global business opportunities through active discussions with international partners.
ILDONG Bioscience, a specialized health supplement subsidiary of the ILDONG Pharmaceutical Group, participated in Vitafoods Asia 2026, the largest healthcare and nutraceutical exhibition in the Asia-Pacific region, showcasing its functional ingredients and proprietary technologies as part of its efforts to expand its global market presence.
On September 7, ILDONG Bioscience (CEO Oh-Hyun Ban) announced its participation in Vitafoods Asia 2026, where it presented its business capabilities in probiotics and a range of functional ingredients.
Held in Bangkok, Thailand, from September 2 to 4, the exhibition provided an opportunity for ILDONG Bioscience to introduce its functional ingredients and R&D capabilities, including:
SPORABLE® (Bacillus coagulans IDCC 1201): A spore-forming probiotic strain associated with sleep quality.
B. lactis FIT (Bifidobacterium animalis subsp. lactis IDCC 4301): A probiotic strain associated with body fat management.
The company also attracted attention by presenting its proprietary quadruple-coating technology, designed to enhance the stability of probiotic ingredients, as well as its comprehensive ODM (Original Design Manufacturing) solutions, offering customized support from raw materials to finished products.
A representative of ILDONG Bioscience stated, "During the exhibition, we also participated in a seminar organized by the Korea Health Supplements Association. We presented our research findings and human clinical trial results on the potential benefits of our proprietary probiotic strain, Bacillus coagulans IDCC 1201, in improving sleep quality, receiving considerable interest from participants."
The representative added, "The promotional samples prepared for distribution at our booth were quickly exhausted, reflecting the strong interest from visitors. We also held active discussions with numerous international companies regarding potential business partnerships involving functional probiotic strains, including those related to sleep quality."
The global probiotics market has recently been experiencing increasingly diversified demand beyond traditional gut health applications, expanding into areas such as skin health, sleep quality, and body fat management.
ILDONG Bioscience continues to expand its global presence across Southeast Asian markets, including Thailand, Malaysia, and Singapore, as well as the United States and Europe. The company is also scheduled to participate in Fi Asia Indonesia, a food and ingredients exhibition taking place in Jakarta, Indonesia, from September 16 to 18, as part of its ongoing efforts to explore new business opportunities in the ASEAN market.
An ILDONG Bioscience representative commented, "We are continuously developing a diverse range of functional ingredients tailored to local market trends while accumulating scientific evidence and data to support their applications."